Back to the main directory
Press Release
- Invitation to Netcompany’s Capital Markets Day 31 October 2025 – Unlocking the Potential by GlobeNewsWire
- CRCAM TOULOUSE 31 : Rapport financier semestriel 30 juin 2025 by GlobeNewsWire
- Sisäpiiritieto, tulosvaroitus: KH Group Oyj laskee vuoden 2025 tulosohjeistustaan by GlobeNewsWire
- The Ensign Group, Inc. Declares Quarterly Dividend of $0.0625 Per Share by GlobeNewsWire
- MoneyHero Group Reports Second Quarter 2025 Results by GlobeNewsWire
- Syndax’s Revuforj® (revumenib) Included in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the Treatment of Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia by GlobeNewsWire
- WeRide Robobus Receives Belgium's First Level 4 Permit, Leading AV Industry with Products Licensed in Seven Countries by GlobeNewsWire
- NeoVolta Celebrates RE+2025 Successes & Recaps Announcements by GlobeNewsWire
- Form 8.3 - Empiric Student Property Plc by GlobeNewsWire
- SAB BIO Highlights Data in Multiple Presentations at EASD by GlobeNewsWire
- TopBuild to Host 2025 Investor Day by GlobeNewsWire
- FG NEXUS ACCELERATES TOTAL ETH HOLDINGS TO 49,715 by GlobeNewsWire
- Statement from Bart Demosky, Executive Vice President and Chief Financial Officer, on Daniel Desjardins, Senior Director, Global Risk Management and Insurance, Receiving the Risk and Insurance Management Society’s Donald M. Stuart Award by GlobeNewsWire
- Alvotech Announces Marketing Approval in Japan of Three New Biosimilars by GlobeNewsWire
- Alvotech Announces Marketing Approval in Japan of Three New Biosimilars by GlobeNewsWire
- TTM Technologies, Inc. Expands Ultra Small Radio Frequency Components Offering for Telecom, Test and Measurement, and COTS Mil-Aero Applications by GlobeNewsWire
- Esperion Partner Otsuka Receives Regulatory Approval to Market NEXLETOL® in Japan for the Treatment of Hypercholesterolemia by GlobeNewsWire
- Xcel Brands Appoints Olin Lancaster as Chief Revenue Officer by GlobeNewsWire
- Spectral AI Named to TIME’s List of World’s Top HealthTech Companies 2025 by GlobeNewsWire
- Vaxart Announces Withdrawal of Reverse Stock Split Proposal by GlobeNewsWire
- neffy® (epinephrine nasal spray) Approved in Japan as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis) by GlobeNewsWire
- Fathom Holdings Prices Underwritten Public Offering of Common Stock by GlobeNewsWire
- Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities by GlobeNewsWire
- Inside information: Carl Haglund appointed as CEO of KH Group Plc by GlobeNewsWire
- Nexxen Launches New $20 Million Ordinary Share Repurchase Program by GlobeNewsWire
- BAINS DE MER MONACO : Assemblée Générale Ordinaire des Actionnaires du 19 septembre 2025 by GlobeNewsWire
- Inside information, profit warning: KH Group Plc lowers its profit guidance for 2025 by GlobeNewsWire
- Man Group PLC : Form 8.3 - Spectris plc by GlobeNewsWire
- Man Group PLC : Form 8.3 - Spirent Communications Plc by GlobeNewsWire
- Regeneron Donates Ebola Treatment for Use in Countries Most at Risk of Outbreaks by GlobeNewsWire
- Skye Presents Phase 1b Data for its Peripheral CB1-inhibiting Antibody, Nimacimab, at European Association for the Study of Diabetes (EASD) Annual Meeting by GlobeNewsWire
- Kraig Biocraft Laboratories Expands Spider Silk Manufacturing with Pursuit of Additional Rearing Center by GlobeNewsWire
- Chijet Motor Company Taps Blockchain Veteran Jason Miller as COO to Spearhead Crypto Treasury Overhaul and Capitalize on Surging Digital Asset Growth by GlobeNewsWire
- Form 8.3 - Life Science REIT Plc by GlobeNewsWire
- Form 8.3 - Unite Group Plc by GlobeNewsWire
- SL Green Realty Corp. Announces Common Stock and Preferred Stock Dividends by GlobeNewsWire
- Déclaration de Bart Demosky, vice-président exécutif et chef de la direction financière, à propos du prix Donald M. Stuart de la Risk and Insurance Management Society décerné à Daniel Desjardins, directeur principal de la gestion globale des risques et de by GlobeNewsWire
- OS Therapies to Participate in Spotlight Panel at BioFuture 2025 October 13 11:00am EDT by Newsfile Corp.
- Markaðsleyfi veitt í Japan fyrir þrjár nýjar líftæknilyfjahliðstæður frá Alvotech by GlobeNewsWire
- Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC by GlobeNewsWire
- Bylvay® (odévixibat) approuvé au Japon pour le traitement d’une maladie rare du foie (CIFP) by GlobeNewsWire
- Nuvini Group CEO Pierre Schurmann to Participate in Keynote Presentation at Brazil Investment Week in London on September 30, 2025 by GlobeNewsWire
- Iterum Therapeutics Provides Business Update by GlobeNewsWire
- GBT Technologies Announced Non- Binding Offer to Acquire Two Hands Corporation; Builds on Merchant Banking Strategy as Wertheim & Company by GlobeNewsWire
- Verrica Pharmaceuticals Announces That Development Partner, Torii Pharmaceutical, Receives Approval for YCANTH® (TO-208) in Japan for the Treatment of Molluscum Contagiosum by GlobeNewsWire
- IMUNON to Present New Translational Data of IMNN-001 Supporting Phase 3 Trial of Immunotherapy for Ovarian Cancer at AACR Special Conference in Cancer Research by GlobeNewsWire
- WaterPure International Announces 2025 Annual Report and Strategic Leadership Additions by GlobeNewsWire
- Polyrizon Submits Pre-Sub Package to the FDA for PL-14 Allergy Blocker by GlobeNewsWire
- Sisäpiiritieto: Carl Haglund on nimitetty KH Group Oyj:n toimitusjohtajaksi by GlobeNewsWire
- West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference Call by GlobeNewsWire